Related Experiment Video
Updated: Jul 11, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
Very early discharge of LOw-Risk ST elevation myocardial infarction patients after successful primary percutaneous
Refai Showkathali1, Radhapriya Yalamanchi1, Aishwarya Mahesh Kumar2
1Department of Cardiology, Apollo Main Hospital, Chennai, India.
Insights
Very-early discharge (VED) within 48 hours after primary percutaneous coronary intervention (PPCI) for low-risk ST-elevation myocardial infarction patients is safe and effective. This approach showed high patient satisfaction and no major adverse cardiac events within six months.
Area of Science:
- Cardiology
- Clinical Medicine
- Interventional Cardiology
Background:
- ST-elevation myocardial infarction (STEMI) requires timely intervention.
- Standard discharge protocols after primary percutaneous coronary intervention (PPCI) may be prolonged for low-risk patients.
- Optimizing hospital resource utilization is crucial in cardiovascular care.
Purpose of the Study:
- To assess the safety and efficacy of very-early discharge (VED; ≤48 hours) post-PPCI in low-risk STEMI patients.
- To compare outcomes of VED with standard discharge protocols.
- To evaluate patient satisfaction and complication rates associated with VED.
Main Methods:
- Prospective study comparing VED (≤48h) versus standard discharge for low-risk STEMI patients undergoing PPCI.
- Outcomes monitored included major adverse cardiac events (MACCE) and minor complications up to 6 months.
- Patient satisfaction and hotline utilization were assessed.
Main Results:
- No MACCE were observed in either group within 6 months.
- Minor complications, such as access site pain, were managed conservatively without readmission.
- Patient satisfaction was high (97.3%), with significant hotline usage (48%).
Conclusions:
- Very-early discharge (≤48 hours) after PPCI for low-risk STEMI patients is feasible and safe.
- Appropriate discharge protocols and follow-up support are essential for successful VED.
- VED may represent an efficient strategy for managing selected STEMI patients post-intervention.
Abstract:
This VEDLOR-STEMI study assessed the safety and efficacy of very-early discharge (VED- ≤ 48 h) after primary percutaneous coronary intervention (PPCI) for patients with ST elevation myocardial infarction who are considered low risk and compared their outcome with low-risk patients who had standard discharge protocol. No major adverse cardiac events (MACCE) occurred within 6 months. Minor complications, like access site pain were managed without readmission. High patient satisfaction (97.3 %) was noted, with 48 % actively utilizing a hotline for queries. VED post-PPCI appears feasible and safe with appropriate discharge protocols and follow-up.
More Related Videos
06:10Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome IV: Interprofessional Care